| 000 | 01623 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517154733.0 | ||
| 264 | 0 | _c20180126 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1938-0682 | ||
| 024 | 7 |
_a10.1016/j.clgc.2017.04.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWong, William W | |
| 245 | 0 | 0 |
_aFactors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer. _h[electronic resource] |
| 260 |
_bClinical genitourinary cancer _c12 2017 |
||
| 300 |
_ae969-e975 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aProstatic Neoplasms, Castration-Resistant _xdrug therapy |
| 650 | 0 | 4 |
_aRadium _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAnderson, Eric M | |
| 700 | 1 | _aMohammadi, Homan | |
| 700 | 1 | _aDaniels, Thomas B | |
| 700 | 1 | _aSchild, Steve E | |
| 700 | 1 | _aKeole, Sameer R | |
| 700 | 1 | _aChoo, C Richard | |
| 700 | 1 | _aTzou, Katherine S | |
| 700 | 1 | _aBryce, Alan H | |
| 700 | 1 | _aHo, Thai H | |
| 700 | 1 | _aQuevedo, Fernando J | |
| 700 | 1 | _aVora, Sujay A | |
| 773 | 0 |
_tClinical genitourinary cancer _gvol. 15 _gno. 6 _gp. e969-e975 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clgc.2017.04.016 _zAvailable from publisher's website |
| 999 |
_c27211547 _d27211547 |
||